Articles

The Fed: Fed’s Mester says interest-rate policy is in a ‘good place’

Interest-rate policy is in a "good place" at present and can move in either direction based on how the economy evolves, said Cleveland Fed President Loretta Mester on Wednesday.

Retirement Weekly: 5 tips to pick your best Medicare plan

Post Content

Project Syndicate: The global economy isn’t out of danger, despite what you’re hearing

El Erian: Stocks, bonds and other investments face a difficult 2024.

: General Motors bondholders also see things to cheer in shareholder-rewards program

GM's stock soared 10% on news of a generous shareholder-rewards program. Bondholders also found reason for good cheer.

: Taiwan president warns of growing ‘military intimidation’ from China as election nears

Taiwanese President Tsai Ing-wen said Wednesday that the people of her country remain 'clear-eyed' about the threat of war with China.

Earnings Results: Dollar Tree is attracting more high-income shoppers

Dollar Tree's stock swung into the green Wednesday, as the discount retailer missed profit expectations because of unexpected costs associated with the recall of over-the-counter drugs.

Financial Crime: Why do people keep suing celebrities like Ronaldo and Tom Brady over their crypto losses?

Post Content

: JPMorgan’s Jamie Dimon sees smaller chance of a soft landing than others

JPMorgan Chief Executive Jamie Dimon says people often get predictions about the weather and the economy wrong.

: Farfetch’s stock drops nearly 50% after company going private in doubt

Shares of Farfetch Ltd. tanked Wednesday after investors seemed to doubt reports that the luxury fashion e-commerce company would be taken private.

: CFPB’s Chopra taking aim at $130 billion in credit card interest, fees Americans paid last year

Here's how a top regulator is proposing to bring more competition to the credit card industry, as Americans increasingly turn to cards for payment.

: Vivos Therapeutics’ stock soars as sleep apnea device gets regulatory clearance

Vivos Therapeutics jumped more than 270% after the FDA cleared the company's devices for severe sleep apnea.

Washington Watch: Shein’s IPO faces frosty reception in Washington

Shein's IPO filing is sparking fresh talk in Washington that the fast-fashion company deserves considerable scrutiny for possible ties to forced labor in China, even as it has made efforts to respond to critics.
1 1,699 1,700 1,701 1,702 1,703 2,306